Novavax COVID-19 vaccine authorized for use in US | Inquirer News

Novavax COVID-19 vaccine authorized for use in US

/ 08:12 AM July 14, 2022

Novavax Covid vaccine highly effective, but not against S.Africa variant

An illustration picture shows vials with Covid-19 Vaccine stickers attached and syringes with the logo of US biotech company Novavax, on November 17, 2020. (Photo by JUSTIN TALLIS / AFP)

Washington, United States — The US Food and Drug Administration on Wednesday authorized Novavax’s COVID-19 shot for use in people aged 18 and over, expanding Americans’ options for vaccination against the disease.

The vaccine – which is produced by an American company – is already available in dozens of other countries. Just three COVID-19 shots, two of them based on messenger RNA technology, have been previously authorized in the United States.

Article continues after this advertisement

The emergency authorization of the Novavax vaccine “offers adults in the United States who have not yet received a COVID-19 vaccine another option that meets the FDA’s rigorous standards for safety, effectiveness, and manufacturing quality,” the FDA’s commissioner Robert Califf said in a statement.

FEATURED STORIES

Administered in two doses three weeks apart, the Novavax vaccine uses a more conventional technology than the mRNA shots, which have been the subject of numerous conspiracy theories, though they have been proven to be safe.

Novavax’s vaccine contains part of the virus that triggers an immune response – the approach used by many other common shots.

Article continues after this advertisement

In clinical trials involving thousands of people in the United States and Mexico, it was 90 percent effective against symptomatic cases of COVID-19. However, the trials were conducted prior to the emergence of the Delta and Omicron variants of the disease.

Article continues after this advertisement

The vaccination rate of adults in the United States has stagnated at around 77 percent.

Article continues after this advertisement

The US government announced this week that it had purchased 3.2 million Novavax doses in anticipation of the FDA decision.

RELATED STORY

Article continues after this advertisement

Novavax COVID-19 vaccine gets emergency use approval in PH

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: COVID-19, Novavax, vaccine

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.